What Happened?
Boston, MA-based Sensei-Biotherapeutics Promoted Erin Colgan as Chief Financial Officer
Date of management change: January 06, 2022
Boston, MA-based Sensei-Biotherapeutics Promoted Erin Colgan as Chief Financial Officer
Driven by world class scientists and an entrepreneurial culture focused on rigorous science, innovative treatments, and data-driven decision making, we discover and develop medicines that have the potential to alter the treatment landscape and contribute value to patients and society. The company has developed a unique drug discovery approach, ImmunoPhage™️, that generates powerful and specific immune responses. Its most advanced program, SNS-301, is currently enrolling patients in Phase 1/2 clinical trials.
Erin Colgan is Chief Financial Officer at Sensei Biotherapeutics. Previously, Erin held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Cleberg Aryn, Tralins Keith, Tchakerian Marineh, Cook Brian, Giroux Dave, Norbury Christie I, Chilinski Adam, Conner Jane, Byrne Ryan, Small Mark, Pacheco Maria
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.